Company intelligence / Profile preview

Medika Natura

Not explicitly stated., Penang / Perak / Selangor / Negeri Sembilan*, Malaysiamedikanatura.com ↗
Ownership
Private
Employees
~75
Development stage
Phase 2
01

Overview

Medika Natura’s lead product, SFK7®/LABEESITY®, a standardized extract from Labisia pumila, has completed Phase 2 RCTs in Malaysia and Indonesia targeting obesity with positive outcomes. The product is now undergoing Phase 3 studies in Malaysia alongside an IND submission to the US FDA. Pre-clinical data also support potential benefits in diabetes and cancer. LABEESITY® has received regulatory approvals as a dietary supplement or traditional medicine in Malaysia, Indonesia, Singapore, the US FDA (as NDI), and is seeking further international clearances.[3][4][5]

Therapeutic areas
Metabolic DisordersEndocrinologyOncologyInfectious Diseases
Modalities
Botanical extractsStandardized herbal compounds[2][3]
Industry
Biotech
02

Drug pipeline

5 assets

SKF7

2

4 more assets in the full pipeline.

Request access →
03

Partnerships

Malaysian Ministry of Agriculture & Food Industry (“anchor company” status)[3]Collaborations with Universiti Sains Malaysia,[3] Universiti Putra Malaysia,[4] Universiti Kebangsaan Malaysia,[4] Institute for Medical Research [IMR], Ministry of Health facilities in multiple Malaysian states,[4] public health facilities in Indonesia,[4] private hospital partner in Hyderabad India.[4]

Beyond the preview

Go deeper on Medika Natura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medika Natura.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call